Revenues (Tables)
 9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Summary of net revenue
The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2020 and 2019:
Three months ended September 30,Nine months ended September 30,
2020201920202019
Products:
Acetadote$218,462 $777,185 $1,527,173 $2,608,160 
Omeclamox-Pak516,066 116,063 640,435 794,205 
Kristalose3,615,557 2,924,237 10,387,046 9,720,434 
Vaprisol406,162 224,940 790,817 724,143 
Caldolor1,416,146 1,170,567 3,677,434 3,543,166 
Vibativ2,813,249 1,451,595 8,551,125 6,156,653 
Other revenue265,047 270,852 1,605,570 1,535,981 
Total net revenues$9,250,689 $6,935,439 $27,179,600 $25,082,742